Nutriband Inc. Common Stock (NTRB)

About NTRB

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and clinical supply agreement for Aversa Fentanyl with Kindeva Drug Delivery. The company was incorporated in…

Sector

Health Care

Industry

Industrial Specialties

Website

nutriband.com/

Fundamentals

1-day range

$3.4$3.59

Market cap

$35.43M

P/E (trailing)

—

P/E (forward)

-15.43

EPS (trailing)

$-0.68

Dividend yield

—

Beta

2.05

Avg. volume

11.0K

Dividend pay date

July 24, 2019

Forecasts

1 analyst ratings

Nutriband Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• NTRB

  Nutriband Inc. Common Stock

  $4.51

  ▼ 2.49%
  Market cap $35.43MP/E —
  $2.8$8.63
• MAMO

  Massimo Group Common Stock

  $1

  ▲ 0.00%
  Market cap $44.56MP/E 16.57
  $0.85$5.59
• LFWD

  Lifeward Ltd. Ordinary Shares

  $7.46

  ▲ 1.29%
  Market cap $20.93MP/E —
  $4.14$10.56
• MYO

  Myomo Inc. Common Stock

  $1.61

  ▼ 3.31%
  Market cap $50.62MP/E —
  $0.605$1.89
• COCH

  Envoy Medical Inc. Class A Common Stock

  $0.7116

  ▼ 2.65%
  Market cap $52.34MP/E —
  $0.3625$1.89
• APT

  Alpha Pro Tech Ltd. Common Stock

  $5.43

  ▼ 0.73%
  Market cap $53.33MP/E 15.27
  $4.34$7.5
• HSCS

  HeartSciences Inc. Common Stock

  $3

  ▼ 3.85%
  Market cap $7.80MP/E —
  $1.63$3.8

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• 12 Health Care Stocks Moving In Monday's Intraday Session
  Benzinga · 8/24/2026

Institutional Ownership

March 31, 2026

Total shares held

346.4K

Total value held

$1.22M

Institutional holders

12